Aggressive B-Cell Lymphoma
2 clinical trials · Condition
◉ Watch Aggressive B-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies (NCT02846935) | Yogen Saunthararajah | 2017-04-25 |
Track Aggressive B-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.